# US 2001/0019722 A1 · Anti-acne chrono patch

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0019722 A1
- Document ID: US20010019722A1
- Status: Published application
- Kind: A1
- Application number: 09/757,416
- Filed: 2001-01-09
- Published: 2001-09-06
- Earliest claimed: 1997-06-20
- Inventors: Spiros Fotinos; David P. O'Halloran
- Web page: https://patentgrep.com/patent/US20010019722A1

## CPC

- A61K 8/368: with carboxyl groups directly bound to carbon atoms of aromatic rings
- A61K 8/0208: {Tissues; Wipes; Patches}
- A61K 8/34: Alcohols
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/055: the aromatic ring being substituted by halogen
- A61K 31/60: Salicylic acid; Derivatives thereof
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61Q 19/00: Preparations for care of the skin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Multi-layer, time release, anti-acne patches and multi-layer, anti-acne patches for the topical application of an anti-acne effective combination of active agents are provided along with a method for making the same. The multi-layer, anti-acne patches contain an anti-acne effective combination of at least two agents selected from the group of an antimicrobial agent, an antiseptic agent, an anti-irritant, a keratolytic agent, a hormone, a hormone agonist and a hormone antagonist. The individual layers of adhesive polymeric matrix material contained in the multi-layer, anti-acne patches provided, may contain identical or disparate combinations of agents constituting the anti-acne effective combination. The multi-layer, anti-acne patches may further contain enhancing agents which improve the efficacy of the anti-acne effective combination present therein.

## Claims

### Claim 1

A multi-layer, time release, anti-acne patch, comprising: a backing film, a release layer and at least two adhesive polymeric matrix layers; wherein each polymeric matrix layer comprises an anti-acne formulation uniformly distributed therein, the formulation comprising an anti-acne effective amount of at least two agents selected from the group consisting of an antimicrobial agent, an antiseptic agent, an anti-irritant, a keratolytic agent, a hormone, a hormone agonist and a hormone antagonist.

### Claim 2 (depends on 1)

The anti-acne patch of claim 1, wherein the anti-acne formulation comprises a keratolytic agent and an anti-irritant.

### Claim 3 (depends on 2)

The anti-acne patch of claim 2, wherein the keratolytic agent is selected from the group consisting of salicylic acid, biologically active esters of salicylic acid, benzoyl peroxide, sulfur, retinoic acid, biologically active esters of retinoic acid, a fruit acid and an alpha hydroxy acid.

### Claim 4 (depends on 2)

The anti-acne patch of claim 2, wherein the keratolytic agent is salicylic acid.

### Claim 5 (depends on 2)

The anti-acne patch of claim 2, wherein the anti-irritant is selected from the group consisting of α-bisabolol, farnesol, chamomile extract and glycyrrhetinic acid.

### Claim 6 (depends on 2)

The anti-acne patch of claim 2, wherein the anti-irritant is α-bisabolol.

### Claim 7 (depends on 2)

The anti-acne patch of claim 2, wherein the keratolytic agent is salicylic acid and wherein the anti-irritant is α-bisabolol.

### Claim 8 (depends on 2)

The anti-acne patch of claim 2, wherein the anti-acne formulation further comprises an antiseptic agent.

### Claim 9 (depends on 8)

The anti-acne patch of claim 8, wherein the antiseptic is Irgasan DP 300, wherein the anti-irritant is α-bisabolol and wherein the keratolytic agent is salicylic acid.

### Claim 10 (depends on 2)

The anti-acne patch of claim 2, wherein the anti-acne formulation further comprises an antimicrobial agent.

### Claim 11

A multi-layer, anti-acne patch, comprising: a backing film, a release layer and at least two adhesive polymeric matrix layers; wherein the at least two adhesive polymeric matrix layers collectively comprise an anti-acne effective combination of at least two agents selected from the group consisting of an antimicrobial agent, an antiseptic agent, an anti-irritant, a keratolytic agent, a hormone, a hormone agonist and a hormone antagonist; and, wherein the different adhesive polymeric matrix layers comprise different components of the anti-acne effective combination.

### Claim 12 (depends on 11)

The anti-acne patch of claim 11, wherein the anti-acne effective combination comprises a keratolytic agent and an anti-irritant.

### Claim 13 (depends on 12)

The anti-acne patch of claim 12, wherein the keratolytic agent is selected from the group consisting of salicylic acid, biologically active esters of salicylic acid, benzoyl peroxide, sulfur, retinoic acid, biologically active esters of salicylic acid, a fruit acid and an alpha hydroxy acid.

### Claim 14 (depends on 12)

The anti-acne patch of claim 12, wherein the keratolytic agent is salicylic acid.

### Claim 15 (depends on 12)

The anti-acne patch of claim 12, wherein the anti-irritant is selected from the group consisting of α-bisabolol, farnesol, chamomile extract and glycyrrhetinic acid.

### Claim 16 (depends on 12)

The anti-acne patch of claim 12, wherein the anti-irritant is α-bisabolol.

### Claim 17 (depends on 12)

The anti-acne patch of claim 12, wherein the keratolytic agent is salicylic acid and the anti-irritant is α-bisabolol.

### Claim 18 (depends on 12)

The anti-acne patch of claim 12, wherein the anti-acne effective combination further comprises an antiseptic agent.

### Claim 19 (depends on 18)

The anti-acne patch of claim 18, wherein the antiseptic is Irgasan DP 300, wherein the anti-irritant is α-bisabolol and wherein the keratolytic agent is salicylic acid.

### Claim 20 (depends on 12)

The anti-acne patch of claim 12, wherein the anti-acne formulation further comprises an antimicrobial agent.

### Claim 21

A multi-layer, anti-acne patch, comprising: a backing film, a release layer, a first adhesive polymeric matrix layer and a second adhesive polymeric matrix layer; wherein the first adhesive polymeric matrix layer is interposed between the backing film and the second adhesive polymeric matrix layer; wherein the second adhesive polymeric matrix layer comprises at least one enhancing agent and wherein the two adhesive polymeric matrix layers collectively comprise an anti-acne effective combination of at least two agents selected from the group consisting of an antimicrobial agent, an antiseptic agent, an anti-irritant, a keratolytic agent, a hormone, a hormone agonist and a hormone antagonist.

### Claim 22 (depends on 21)

The anti-acne patch of claim 21, wherein the at least one enhancing agent is selected from the group consisting of a skin barrier disrupter, a penetration enhancer, a skin conditioner and an anti-irritant.

### Claim 23 (depends on 22)

The anti-acne patch of claim 22, wherein the at least one enhancing agent is selected from the group consisting of sodium lauryl sulfate and low molecular weight (C6-C10) alkyl phenol ethoxylates.

### Claim 24 (depends on 23)

The anti-acne patch of claim 23, wherein the first adhesive polymeric matrix layer comprises salicylic acid.

### Claim 25 (depends on 22)

The anti-acne patch of claim 22, wherein the at least one enhancing agent is selected from the group consisting of polar lipids, fatty acids, low molecular weight ethoxylated fatty alcohols, solubilizers and alpha hydroxy acids.

### Claim 26 (depends on 25)

The anti-acne patch of claim 25, wherein the first adhesive polymeric matrix layer comprises a keratolytic agent selected from the group consisting of salicylic acid, biologically active esters and salts of salicylic acid, retinol, and the biologically active esters and salts of retinol.

### Claim 27 (depends on 22)

The anti-acne patch of claim 22, wherein the at least one enhancing agent is selected from the group consisting of glycerol and urea.

### Claim 28 (depends on 27)

The anti-acne patch of claim 27, wherein the first adhesive polymeric matrix layer comprises a keratolytic agent selected from the group consisting of an alpha hydroxy acid, salicylic acid and sulfur.

### Claim 29 (depends on 22)

The anti-acne patch of claim 22, wherein the at least one enhancing agent is selected from the group consisting of an anti-irritant.

### Claim 30 (depends on 29)

The anti-acne patch of claim 29, wherein the first adhesive polymeric matrix layer comprises a keratolytic agent.

### Claim 31 (depends on 21)

The anti-acne patch of claim 21, wherein the anti-acne effective combination comprises a keratolytic agent and an anti-irritant.

### Claim 32 (depends on 31)

The anti-acne patch of claim 31, wherein the keratolytic agent is selected from the group consisting of salicylic acid, benzoyl peroxide, sulfur, retinoic acid, a fruit acid and an alpha hydroxy acid and wherein the and wherein the anti-irritant is selected from the group consisting of α-bisabolol, farnesol, chamomile extract and glycyrrhetinic acid.

### Claim 33 (depends on 31)

The anti-acne patch of claim 31, wherein the keratolytic agent is salicylic acid and wherein the anti-irritant is α-bisabolol.

### Claim 34 (depends on 31)

The anti-acne patch of claim 31, wherein the anti-acne effective combination further comprises an antiseptic agent.

### Claim 35 (depends on 34)

The anti-acne patch of claim 34, wherein the antiseptic is Irgasan DP 300, wherein the anti-irritant is α-bisabolol and wherein the keratolytic agent is salicylic acid.

### Claim 36 (depends on 31)

The anti-acne patch of claim 31, wherein the anti-acne effective combination further comprises an antimicrobial agent.

### Claim 37

A multi-layer, anti-acne patch, comprising: a backing film, a release layer, a first adhesive polymeric matrix layer and a second adhesive polymeric matrix layer; wherein the first adhesive polymeric matrix layer is interposed between the backing film and the second adhesive polymeric matrix layer; wherein the first adhesive polymeric matrix layer comprises urea and wherein the at least two adhesive polymeric matrix layers collectively comprise an anti-acne effective combination of at least two agents selected from the group consisting of an antimicrobial agent, an antiseptic agent, an anti-irritant, a keratolytic agent, a hormone, a hormone agonist and a hormone antagonist.

### Claim 38 (depends on 21)

A method of manufacturing the multi-layer, time release, anti-acne patch of claim 21, comprising:
a) casting the first adhesive polymeric matrix layer on a liner;
b) laminating the product of (a) on the backing film;
c) casting the second adhesive polymeric matrix layer on the release layer;
d) removing the liner from the product of (b); and,
e) laminating the product of (c) to the product of (d).
